125 results
Page 2 of 7
6-K
EX-99.1
75t1jn
17 Oct 22
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of
7:16am
6-K
EX-99.1
wj9ub p750dhv
3 Oct 22
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders
5:43pm
6-K
EX-99.1
1riougty10nnci5 5ga
26 Sep 22
Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by
7:18am
6-K
EX-99.1
0bejomdl3sok2 ya
12 Sep 22
Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for etigilimab plus anti-PD1 therapy
8:17am
6-K
EX-99.1
s89tjdagjpeb
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
ju72p g0p
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-99.1
0dexl4g o1yt
5 Jul 22
Current report (foreign)
4:15pm
6-K
EX-99.1
6iyau6wghwwrlq
2 Jun 22
Mereo Also Updates Capital Allocation and Portfolio Prioritization Plan
9:07am
6-K
EX-99.1
ppc5q
26 May 22
Current report (foreign)
5:11pm
6-K
EX-99.1
cy24nw3jiut
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
EX-99.1
pan6l5d6czcke3
9 May 22
Current report (foreign)
8:06am
6-K
0ruz7aql b9q6e0r
9 May 22
Current report (foreign)
8:06am